查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1722985

2025 年至 2033 年早期毒性測試市場規模、佔有率、趨勢及按技術、最終用戶和地區分類的預測

Early Toxicity Testing Market Size, Share, Trends and Forecast by Technique, End User, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球早期毒性測試市場規模價值 13.7 億美元。展望未來， IMARC Group估計到 2033 年市場規模將達到 25.7 億美元，2025 年至 2033 年的複合年成長率為 6.84%。歐洲目前佔據市場主導地位，2024 年的市佔率將超過 34.0%。受藥物開發活動增加、監管要求嚴格以及替代測試方法進步的推動，市場正在經歷顯著成長。對預測毒理學解決方案的需求不斷成長以及動物試驗的減少進一步推動了市場成長，有助於擴大早期毒性測試市場佔有率。

新化合物的早期毒性測試用於開發藥物和擴展現有分子的治療潛力。它在臨床前階段對各種生物系統進行，以研究產品的物種、器官和劑量特定毒性作用。它可以透過多種方式進行，包括在動物體內進行、在實驗室中使用分析進行體外電腦模擬以及在電腦上進行。它也用於研究物質的意外接觸。如今，候選藥物後期失敗的高成本影響促使製藥公司對研究產品進行早期毒性測試。

早期毒性測試市場趨勢：

接觸有毒化學物質是透過皮膚接觸、口服或吸入發生的。因此，早期毒性測試已成為各種工業應用中確定產品毒性程度並確保其對人類消費和環境安全的關鍵過程。例如，它廣泛應用於食品和飲料（F&B）行業，以識別不良影響並表徵產品中的潛在毒素。此外，疾病盛行率的上升以及對新型藥物和生物製品的需求也促使人們採用早期毒性測試，以防止候選藥物在臨床試驗中失敗。此外，監管機構實施的與公共健康福利相關的嚴格規定對早期毒性測試的需求產生了積極影響，以確定監管批准所需藥物的可行性。除此之外，農藥使用量的增加會對人類健康構成風險，這促進了農業產業使用早期毒性測試。此外，對化妝品的需求不斷成長，正在擴大全球化妝品成分早期毒性測試的應用。

本報告回答的關鍵問題

  • 早期毒性測試市場有多大？早期毒性檢測市場未來前景如何？
  • 推動早期毒性測試市場發展的關鍵因素有哪些？
  • 哪個地區佔據最大的早期毒性測試市場佔有率？
  • 全球早期毒性測試市場領先的公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球早期毒性測試市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依技術

  • 體內
  • 體外
  • 電腦模擬

第7章：市場區隔：依最終用戶

  • 製藥業
  • 食品工業
  • 化學工業
  • 化妝品產業
  • 其他

第8章：市場區隔：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第9章：SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 10 章：價值鏈分析

第 11 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 12 章：價格分析

第 13 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Agilent Technologies Inc.
    • Bio-Rad Laboratories Inc.
    • Bruker Corporation
    • Charles River Laboratories International Inc.
    • Danaher Corporation
    • Enzo Biochem Inc.
    • Eurofins Scientific SE
    • Evotec AG
    • Merck KGaA
    • PerkinElmer Inc.
    • SGS SA
    • Thermo Fisher Scientific Inc.
    • WuXi AppTec
Product Code: SR112025A5651

The global early toxicity testing market size was valued at USD 1.37 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 2.57 Billion by 2033, exhibiting a CAGR of 6.84% from 2025-2033. Europe currently dominates the market, holding a market share of over 34.0% in 2024. The market is experiencing significant growth driven by increasing drug development activities, stringent regulatory requirements, and advancements in alternative testing methods. Growing demand for predictive toxicology solutions and reduced animal testing further fuels market growth, contributing to the expanding early toxicity testing market share.

Early toxicity testing of new compounds is used to develop drugs and the extension of the therapeutic potential of existing molecules. It is carried out at pre-clinical stages on various biological systems to investigate the species, organs, and dose-specific toxic effects of a product. It can be performed in multiple ways, including in vivo on animals, in vitro in laboratories using assays, and in silico on a computer. It is also utilized for studying accidental exposures to a substance. Nowadays, the high-cost impact of late-stage failures of drug candidates is encouraging pharma companies to conduct early toxicity testing on investigational products.

Early Toxicity Testing Market Trends:

Exposure to toxic chemicals occurs through skin contact, oral intake, or inhalation. Therefore, early toxicity testing has become a crucial process in various industrial applications for determining the degree of toxicity in products and ensuring that they are safe for human consumption and the environment. For example, it is extensively utilized in the food and beverage (F&B) industry to identify the adverse effects and characterize potential toxicants in products. Moreover, the rising prevalence of diseases and the requirement of novel drugs and biological products are encouraging the adoption of early toxicity testing to prevent the failure of candidate drugs at clinical trials. In addition, stringent regulations relating to public health welfare imposed by regulatory authorities are positively influencing the demand for early toxicity testing to determine the viability of drugs required for regulatory approval. Apart from this, the increasing usage of pesticides can pose risks to human health, which is promoting the use of early toxicity testing in the agriculture industry. Furthermore, the escalating demand for cosmetic products is expanding the application of early toxicity testing of cosmetic ingredients worldwide.

Key Market Segmentation:

Breakup by Technique:

  • In Vivo
  • In Vitro
  • In Silico

Breakup by End User:

  • Pharmaceuticals Industry
  • Food Industry
  • Chemicals Industry
  • Cosmetics Industry
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Charles River Laboratories International Inc., Danaher Corporation, Enzo Biochem Inc., Eurofins Scientific SE, Evotec A.G., Merck KGaA, PerkinElmer Inc., SGS S.A., Thermo Fisher Scientific Inc. and WuXi AppTec.

Key Questions Answered in This Report

  • 1.How big is the early toxicity testing market?
  • 2.What is the future outlook of early toxicity testing market?
  • 3.What are the key factors driving the early toxicity testing market?
  • 4.Which region accounts for the largest early toxicity testing market share?
  • 5.Which are the leading companies in the global early toxicity testing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Early Toxicity Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technique

  • 6.1 In Vivo
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 In Vitro
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 In Silico
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by End User

  • 7.1 Pharmaceuticals Industry
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Food Industry
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Chemicals Industry
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cosmetics Industry
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Agilent Technologies Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Bio-Rad Laboratories Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Bruker Corporation
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Charles River Laboratories International Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Danaher Corporation
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Enzo Biochem Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 Eurofins Scientific SE
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Evotec A.G.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Merck KGaA
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
    • 13.3.10 PerkinElmer Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
    • 13.3.11 SGS S.A.
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
    • 13.3.12 Thermo Fisher Scientific Inc.
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio
      • 13.3.12.3 Financials
      • 13.3.12.4 SWOT Analysis
    • 13.3.13 WuXi AppTec
      • 13.3.13.1 Company Overview
      • 13.3.13.2 Product Portfolio
      • 13.3.13.3 Financials

List of Figures

  • Figure 1: Global: Early Toxicity Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Early Toxicity Testing Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Early Toxicity Testing Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Early Toxicity Testing Market: Breakup by Technique (in %), 2024
  • Figure 5: Global: Early Toxicity Testing Market: Breakup by End User (in %), 2024
  • Figure 6: Global: Early Toxicity Testing Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Early Toxicity Testing (In Vivo) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Early Toxicity Testing (In Vivo) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Early Toxicity Testing (In Vitro) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Early Toxicity Testing (In Vitro) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Early Toxicity Testing (In Silico) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Early Toxicity Testing (In Silico) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Early Toxicity Testing (Pharmaceuticals Industry) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Early Toxicity Testing (Pharmaceuticals Industry) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Early Toxicity Testing (Food Industry) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Early Toxicity Testing (Food Industry) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Early Toxicity Testing (Chemicals Industry) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Early Toxicity Testing (Chemicals Industry) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Early Toxicity Testing (Cosmetics Industry) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Early Toxicity Testing (Cosmetics Industry) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Early Toxicity Testing (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Early Toxicity Testing (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: North America: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: North America: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: United States: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: United States: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Canada: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Canada: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Asia-Pacific: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Asia-Pacific: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: China: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: China: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Japan: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Japan: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: India: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: India: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: South Korea: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: South Korea: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Australia: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Australia: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Indonesia: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Indonesia: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Others: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Others: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Europe: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Europe: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Germany: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Germany: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: France: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: France: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: United Kingdom: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: United Kingdom: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Italy: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Italy: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Spain: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Spain: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Russia: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Russia: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Others: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Others: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Latin America: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Latin America: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Brazil: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Brazil: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Mexico: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Mexico: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Others: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Others: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Middle East and Africa: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Middle East and Africa: Early Toxicity Testing Market: Breakup by Country (in %), 2024
  • Figure 71: Middle East and Africa: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Global: Early Toxicity Testing Industry: SWOT Analysis
  • Figure 73: Global: Early Toxicity Testing Industry: Value Chain Analysis
  • Figure 74: Global: Early Toxicity Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Early Toxicity Testing Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Early Toxicity Testing Market Forecast: Breakup by Technique (in Million USD), 2025-2033
  • Table 3: Global: Early Toxicity Testing Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 4: Global: Early Toxicity Testing Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Early Toxicity Testing Market: Competitive Structure
  • Table 6: Global: Early Toxicity Testing Market: Key Players